Ronster schreef op 18 februari 2022 17:09:
Paris, France and Camberley, UK – 18 February 2022 – Novacyt S.A. (EURONEXT
GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics,
announces that it was notified by Biosynex SA (“Biosynex”) on 18 February 2022 that, as
at 14 February 2022, Biosynex's holding in the Company on a voting and capital basis is
4.04% (2,855,959 shares).